Trademarkia Logo

Canada

C$
GW PHARMA
REGISTERED

on 4 Nov 2020

Last Applicant/ Owned by

Jazz Pharmaceuticals Operations UK Limited

Building 730 Kent Science ParkSittingbourne, KentEngland, ME9 8AG

GB

Serial Number

1826311 filed on 8th Mar 2017

Registration Number

TMA1086976 registered on 4th Nov 2020

Registration expiry Date

4th Nov 2030

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

GW PHARMA

Trademark usage description

pharmaceutical and veterinary preparations and substances for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex Read More

Classification Information


Class [005]
Pharmaceutical and veterinary preparations and substances for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; pharmaceutical preparations and substances for the treatment of epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; herbs for medicinal purposes, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal herbs for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal oils for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal infusions for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; pure extracts of medicinal plants and herbs for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; nutritional and dietary supplements for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; herb teas for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy, all of the foregoing excluding suppositories, tablets, namely, laxative tablets and anti-diarrheal tablets, pharmaceutical preparations in topical, semi-liquid dosage forms, namely, topical dermatological creams and ointments, liquid-containing pads for treating haemorrhoid-related conditions and for cleansing the rectal and vaginal areas, distributorships in the field of suppositories and pharmaceutical preparations in the forms of tablets, topical semi-solid dosages, namely, topical creams and ointments, and liquid-containing pads to drug wholesalers, healthcare providers, managed care organizations and retail pharmacy services and retail grocery stores.


Classification kind code

11

Mark Details


Serial Number

1826311

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 110
on 28th Aug 2019
Proposed Opposition
Submitted for opposition 42
on 26th Jun 2019
Advertised
Submitted for opposition 26
on 6th Jun 2019
Approved
Submitted for opposition 27
on 15th Apr 2019
Approval Notice Sent
Submitted for opposition 15
on 30th Jul 2018
Correspondence Created
Submitted for opposition 22
on 17th Jan 2018
Search Recorded
Submitted for opposition 20
on 17th Jan 2018
Examiner's First Report
Submitted for opposition 31
on 10th Mar 2017
Formalized
Submitted for opposition 1
on 9th Mar 2017
Created
Submitted for opposition 30
on 8th Mar 2017
Filed